Sponsor or institution

Clinical trials and research at Melanoma Institute Australia

• 7Clinical trials
• 7Countries

Newest trials

All recruiting trials (7)

• Removing only the main affected lymph node versus standard full lymph node removal for stage III melanoma

  This trial tests whether removing just the largest affected lymph node after six weeks of pre-surgery immunotherapy works as well as removing all lymph nodes in the area for people with stage III cutaneous melanoma in preventing recurrence over two years.

  Recruiting at 4 sites Melanoma Institute Australia · Los Angeles, California and 7 other locations · NCT07049276

• Neoadjuvant ipilimumab, relatlimab, and nivolumab combinations for resectable cutaneous and mucosal melanoma

  This phase 2 trial will test several immunotherapy combinations given before surgery to try to reduce recurrence in adults with resectable stage 3 cutaneous melanoma or resectable mucosal melanoma, including patients predicted or known to respond poorly to standard anti‑PD‑1 therapy.

  Recruiting Phase 2 Melanoma Institute Australia · Wollstonecraft, New South Wales · NCT06999980

• Combining targeted radiotherapy with immunotherapy for advanced melanoma

  This study is testing if combining targeted radiotherapy with immunotherapy can help people with advanced melanoma live better and longer compared to just using immunotherapy alone.

  Recruiting at 5 sites Phase 2 Melanoma Institute Australia · Westmead, New South Wales and 4 other locations · NCT06767306

• Personalized immunotherapy platform for cancer treatment

  This study is testing a new way to identify melanoma and skin cancer patients who might not respond well to immunotherapy by analyzing their tumor samples.

  Recruiting at 3 sites Melanoma Institute Australia · Sydney, New South Wales and 2 other locations · NCT06536257

• Neoadjuvant therapy using Nivolumab and Relatlimab for skin cancer

  This study is testing a new combination of two immunotherapy drugs, Nivolumab and Relatlimab, to see if they can help people with advanced skin cancer do better before surgery.

  Recruiting Phase 2 Melanoma Institute Australia · Wollstonecraft, New South Wales · NCT06288191

• Neoadjuvant immunotherapy for Merkel cell carcinoma

  This study is testing a combination of two immune treatments to see if they can help people with a type of skin cancer called Merkel cell carcinoma have better outcomes before surgery.

  Recruiting Phase 2 Melanoma Institute Australia · Wollstonecraft, New South Wales · NCT06151236

• Combining immunotherapy and radiotherapy for melanoma brain metastases

  This study is testing if combining two immune therapies with targeted radiation can help people with melanoma that has spread to the brain feel better and live longer.

  Recruiting at 8 sites Phase 2 Melanoma Institute Australia · Sydney, New South Wales and 8 other locations · NCT03340129

Quick answers

How many clinical trials run by Melanoma Institute Australia are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in Australia (7 trials), Canada (2 trials), Norway (1 trial), Israel (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →